News

The Angel Capital Association is delighted to announce the four finalists for the Luis Villalobos Award, a highly regarded, North American-wide award that honors ingenuity, creativity and innovation among startups backed by ACA members: Catalyst OrthoScience, CNote, Oculogica and PhotoniCare. 

As the Vikings prepare to play the Saints in the playoffs, Hall of Fame quarterback Brett Favre is making news for his comments about the last time the two teams met in the 2009 playoffs, telling KFAN radio about what he considers an undiagnosed head injury.

While Minneapolis is preparing to host Super Bowl 2018 in just a few short weeks, Twin Cities’ researchers are coming together to present their innovations to the public in an array of events.

Concussions are notoriously difficult to diagnose. Hennepin County Medical Center neurosurgeon and researcher Dr. Uzma Samadani would know. For more than five years, she’s been working to change the way brain injuries are diagnosed and defined through Oculogica, a medical technology startup she co-founded to identify brain injuries.

Measuring whether a heart is working correctly is a relatively straightforward task, because the heart has a straightforward purpose: reliably pumping blood.

Oculogica demonstrates the ability to detect the physiological impact of Intracranial Pressure in Journal of Neurosurgery Article.

Oculogica, a neuro-diagnostic company, has been issued a patent for its novel neuro-optic tracking device to detect elevated intracranial pressure via eye-tracking.

A novel experimental trial, led by one University of Minnesota professor, is working to treat traumatic brain injuries and concussions — without surgery.

When the 15-year-old ninth-grader first met Dr. Uzma Samadani, her back pain was so severe she couldn’t participate in gym class at Richfield High School. Climbing stairs was a chore and she couldn’t tie her own shoes. Her right leg was showing signs of paralysis.

An electric stimulator, placed twice daily on a patient’s neck, could end up providing effective treatment for moderate traumatic brain injury — a disorder that currently has no proven treatment.